Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans

被引：32

作者：

Hoppe J.E. ^{[1
]}

Frey P. ^{[1
]}

机构：

[1] University Children's Hospital, D-72076 Tübingen

来源：

European Journal of Clinical Microbiology and Infectious Diseases | 1999年 / 18卷 / 3期

关键词：

Candida Albicans; Candida Species; Clinical Microbiology; Candida Tropicalis; Candida Glabrata;

D O I：

10.1007/s100960050256

中图分类号：

学科分类号：

摘要：

Six commercial tests (Albicans ID®, bioMerieux, France; CandiSelect®, Sanofi Diagnostics Pasteur, France, CHROMagar® Candida, Becton Dickinson, USA; Fluoroplate® Candida, Merck, Germany, Fongiscreen® 4H, Sanofi Diagnostics Pasteur; and Murex Candida albicans, Murex Diagnostics, USA) and the germ-tube test for presumptive identification of Candida albicans were evaluated using clinical isolates of Candida albicans (n = 350) and of non-albicans yeasts (n = 135). Sensitivities and specificities of all tests regarding the identification of Candida albicans were greater than 97%. The two tests that also allow presumptive identification of some non-albicans yeasts (CHROMagar® Candida and Fongiscreen® 4H) did not identify all isolates of Candida glabrata and Candida tropicalis. In addition, CHROMagar® Candida identified as Candida glabrata some isolates belonging to different species of non-albicans yeasts.

引用

页码：188 / 191

页数：3

共 18 条

[11]

Heelan J.S., Siliezar D., Coon K., Comparison of rapid testing methods for enzyme production with the germ tube method for presumptive identification of Candida albicans, Journal of Clinical Microbiology, 34, pp. 2847-2849, (1996)

[12]

Odds F.C., Bernaerts R., CHROMagar® Candida, a new differential isolation medium for presumptive identification of clinically important Candida species, Journal of Clinical Microbiology, 32, pp. 1923-1929, (1994)

[13]

Beighton D., Ludford R., Clark D.T., Brailsford S.R., Pankhurst C.L., Tinsley G.F., Fiske J., Lewis D., Daly B., Khalifa N., Marren V., Lynch E., Use of CHROMagar® Candida medium for isolation of yeasts from dental samples, Journal of Clinical Microbiology, 33, pp. 3025-3027, (1995)

[14]

Pfaller M.A., Houston A., Coffmann S., Application of CHROMagar® Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei and Candida (Torulopsis) glabrata, Journal of Clinical Microbiology, 34, pp. 58-61, (1996)

[15]

Bouchara J.P., Declerck P., Cimon B., Planchenault C., De Gentile L., Chabasse D., Routine use of CHROMagar® Candida medium for presumptive identification of Candida yeast species and detection of mixed fungal populations, Clinical Microbiology and Infection, 2, pp. 202-208, (1996)

[16]

San-Millan R., Ribacoba L., Ponton J., Quindos G., Evaluation of a commercial medium for identification of Candida species, European Journal of Clinical Microbiology & Infectious Diseases, 15, pp. 153-158, (1996)

[17]

Freydiere A.M., Evaluation of CHROMagar® Candida plates, Journal of Clinical Microbiology, 34, (1996)

[18]

Quindos G., Lipperheide V., Ponton J., Evaluation of two commercialized systems for the rapid identification of medically important yeasts, Mycoses, 36, pp. 299-303, (1993)

← 1 2 →